Anika Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-04-29 09:22:16 ET ANIK

Published on 04/29/2026 at 09:22 am EDT

Anika Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 29.61 million compared to USD 26.17 million a year ago. Net loss was USD 5.06 million compared to USD 4.87 million a year ago.

Basic loss per share from continuing operations was USD 0.37 compared to USD 0.28 a year ago. Diluted loss per share from continuing operations was USD 0.37 compared to USD 0.28 a year ago. Basic loss per share was USD 0.37 compared to USD 0.34 a year ago.

Diluted loss per share was USD 0.37 compared to USD 0.34 a year ago.